The market opened in green on May 17, 2021, overall volumes in futures & options currently stand at 2,72,84,719 contracts with a turnover of Rs. 25,40,178.09 crore.

Hester Biosciences is tying up with Gujarat Biotechnology Research Centre (Government of Gujarat) along with OmniBRx for manufacturing the COVID vaccine.

Shilpa Medicare Limited via its wholly-owned subsidiary, Shilpa Biologicals Private Limited (SBPL) has entered into a three-year definitive agreement with Dr Reddy's Laboratories Limited (DRL) for production-supply of Sputnik V vaccine (used for COVID-19) from its integrated biologics R&D-cum-manufacturing centre at Dharwad (Karnataka).

Trident: The company’s bath & bed linen segment registered revenue growth of 52 per cent and 109 per cent a YoY basis. 92 per cent capacity utilization in bed linen segment. 

In a transition phase to stage-2, the stock price is above 150-DMA and 200-DMAs. The 150-DMA is above the 200-DMA while the latter has turned up. 

The data of the Association of Mutual Funds in India (AMFI) shows that a regular plan dominates the SIP and has better longevity than a direct plan. Read onto find out more.

In a press release, Welspun India stated that the company is set to work with Target Corporation in the USA to achieve business growth. Reacting to the announcements made post the meeting held of its board of directors, its stock jumped by more than 11 per cent. 

The shares of UPL Ltd climbed over 8 per cent on Friday, touching its 52-week high of Rs 764.45 per share, after JP Morgan released a coverage report on the company, highlighting its growth potential. 

Alembic Pharmaceuticals Limited, a leading pharmaceutical company, announced today that it has received approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lurasidone Hydrochloride tablets (20 mg, 40 mg, 60 mg, 80 mg, and 120 mg).